TürkiyeResearch and clinical trials
Attention and behavior problems more common in 27 children with hereditary spherocytosis in Gaziantep
Gaziantep City Hospital studied 27 children.
Blood and immune system diseases
An inherited blood disease in which red blood cells are round like a ball. These cells are destroyed early in the spleen. Anemia, jaundice and an enlarged spleen occur.
Not part of the panel of Türkiye's National Newborn Screening Programme (heel-prick test). Source
This page is translated from the Turkish original.
This disease is followed through the “Blood and immune system diseases” group.
Red blood cells are normally flat and flexible. In this disease, some proteins in the cell membrane are faulty. The cells become stiff and take on a ball shape. These cells get trapped in the spleen and break down early. The disease has different forms, from mild to severe.
Symptoms vary greatly from person to person. In the mild form, there may be no symptoms at all.
During the examination, the doctor checks the size of the spleen. Ball-shaped cells are seen in the blood count and blood smear. Tests showing the breakdown of blood and special cell membrane tests are done. A genetic test is not always needed, but it can clarify the diagnosis.
In moderate and severe forms, supplements of folate, a B vitamin, are recommended. Blood transfusions may be needed for severe anemia. In severe cases, removing the spleen greatly improves the anemia. In children, this surgery is usually delayed for a few years. Vaccines are given before the surgery. In mild cases, the spleen may not need to be removed. If gallstones cause problems, the gallbladder may be removed. The doctor who follows the disease decides which treatment is suitable.
About three quarters of cases are passed on through dominant inheritance. An affected parent has a 1 in 2 chance of passing it to each child. Sometimes the gene change appears for the first time in the family. The remaining cases are passed on through recessive inheritance. In this case, for a couple who are both carriers, the chance of having an affected child is 1 in 4 in each pregnancy. If the disease is in the family, checking the children is recommended. Genetic counselling guides the family.
Source: MedlinePlus Genetics: Hereditary spherocytosis · MedlinePlus: Hereditary spherocytic anemia · NORD: Hereditary Spherocytosis
These facts are taken from Orphanet and MedlinePlus records (last checked: October 7, 2026). Frequency values are approximate ranges.
Non-profit patient and family organizations in Türkiye working on this disease or disease group. Links are for information; Doktorclub is not affiliated with these organizations and does not endorse them.
We could not find a patient association specific to this disease.
For all rare diseases: Nadir Hastalıklar Federasyonu
Doktorclub does not diagnose, recommend treatments or refer you to hospitals or doctors. These pages are meant to help you talk with your doctor.
TürkiyeResearch and clinical trials
Gaziantep City Hospital studied 27 children.
TürkiyeDiagnosis and screening
At Marmara University, 18 pediatric patients were studied genetically.
A clinical trial is a regulated study that tests whether a new treatment is safe and whether it works, in patients who volunteer. Most trials look for a certain age, genetic change and health condition. Taking part is voluntary.
ClinicalTrials.gov currently lists no active interventional studies for this disease. Last checked: October 7, 2026.
See all studies on ClinicalTrials.gov · Joining clinical trials
GlobalHealth policy
The International Pediatric Nephrology Association published its recommendations for diagnosing and treating atypical HUS in children.
GlobalResearch and clinical trials
Researchers re-examined the data from a large drug study.
TürkiyeResearch and clinical trials
A face-to-face survey was conducted with 104 PNH patients at 18 centers in Türkiye.
These codes identify the disease in international classifications and databases. They can help when you talk with your doctor or look for reliable sources.
Orphanet code: ORPHA:822
No separate ICD-11 code; WHO classifies this disease under: 3A10.Y
Codes checked against WHO ICD-11 and Orphanet on October 7, 2026.
This page provides general information and does not replace diagnosis or treatment. Talk to your doctor about symptoms, diagnosis and treatment.